$PLX Q2 '26 Earnings Results & Recap Protalix BioTherapeutics reported total revenue of $19.9 million for the three months ended June 30, 2026, with net income of $3.8 million, up from $0.2 million in the prior year period.
$PLX Q2 '26 Earnings Results & Recap Protalix BioTherapeutics reported total revenue of $19.9 million for the three months ended June 30, 2026, with net income of $3.8 million, up from $0.2 million in the prior year period.